Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Decrease of chronic graft-versus-host disease by adding anti-human thymocyte globulin to the conditioning regimen].

Bing-yi Wu1, Kun-yuan Guo, Chao-yang Song

  • 1Department of Hematology, Zhujiang Hospital, Guangzhou 510280, China.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|March 3, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NRF1 Activates the AMPK/SIRT1/PGC-1α/TFAM Axis to Suppress EMT and Tumor Progression in Lung Adenocarcinoma.

Cancer genomics & proteomics·2026
Same author

Lactiplantibacillus Plantarum O126 Postbiotics Boost growth, Antioxidant levels, Disease resistance, and Gut Health in Sea Cucumber (Apostichopus japonicus).

Probiotics and antimicrobial proteins·2026
Same author

Lumpy skin disease virus protein LSDV122 impairs IFN-I receptor complex formation to evade host innate immunity.

PLoS pathogens·2026
Same author

Rutin Suppresses EMT and Induces Mitochondrial Biogenesis <i>via</i> ER Stress-linked AMPK/SIRT1 Signaling in Prostate Cancer Cells.

Cancer genomics & proteomics·2025
Same author

SCAMP3 and EPS8 Cooperatively Regulate EGFR Signaling to Promote Enzalutamide Resistance and Metastatic Potential in Prostate Cancer.

Cancer genomics & proteomics·2025
Same author

Verbascoside Suppresses Epithelial-Mesenchymal Transition and Mitochondrial Biogenesis by Targeting Anti-senescence Signaling in Castration-resistant Prostate Cancer.

Cancer genomics & proteomics·2025

Adding anti-human thymocyte globulin (ATG) to the conditioning regimen for allogeneic peripheral blood stem cell transplantation (allo-PBSCT) significantly reduced graft-versus-host disease (GVHD). This improved patient quality of life without impacting stem cell engraftment.

Area of Science:

  • Hematology
  • Immunology
  • Transplantation Medicine

Context:

  • Allogeneic peripheral blood stem cell transplantation (allo-PBSCT) is a critical treatment for hematologic malignancies.
  • Graft-versus-host disease (GVHD) remains a significant complication, impacting patient outcomes and quality of life.
  • Conditioning regimens are essential for allo-PBSCT success but can be associated with toxicity.

Purpose:

  • To evaluate the efficacy of incorporating anti-human thymocyte globulin (ATG) into the fludarabine, busulfan, and cyclophosphamide (FBC) conditioning regimen.
  • To assess the impact of ATG on the incidence of acute and chronic graft-versus-host disease (GVHD).
  • To determine the effect of ATG on the quality of life in patients undergoing allo-PBSCT.

Summary:

  • A randomized study compared allo-PBSCT with an FBC regimen plus ATG (study group, 19 patients) versus FBC alone (control group, 24 patients).

Related Experiment Videos

  • The study group demonstrated significantly lower rates of acute GVHD (6/19 vs. 15/24) and chronic GVHD (7/19 vs. 19/24).
  • Karnofsky scores, indicative of quality of life, were significantly higher in the ATG group, suggesting improved patient well-being.

    • Impact:

    • Addition of ATG to the FBC conditioning regimen effectively mitigates both acute and chronic GVHD following allo-PBSCT.
    • ATG supplementation enhances the quality of life for patients undergoing allo-PBSCT.
    • ATG does not adversely affect critical parameters such as stem cell engraftment or neutrophil recovery time.